First Patient Enrolled in ASCO's Multi-State CDK Study for Older Adults With Metastatic Breast Cancer
December 19, 2024
December 19, 2024
ALEXANDRIA, Virginia, Dec. 19 (TNSres) -- The American Society of Clinical Oncology issued the following news release:
* * *
Sites now enrolling in Arizona, Florida, Georgia, and South Carolina
* * *
The American Society of Clinical Oncology (ASCO) has launched the CDK4/6 Inhibitor Dosing Knowledge (CDK) Study to investigate personalized dosing strategies for CDK4/6 inhibitors in older adults with metastatic breast cancer. These patients often . . .
* * *
Sites now enrolling in Arizona, Florida, Georgia, and South Carolina
* * *
The American Society of Clinical Oncology (ASCO) has launched the CDK4/6 Inhibitor Dosing Knowledge (CDK) Study to investigate personalized dosing strategies for CDK4/6 inhibitors in older adults with metastatic breast cancer. These patients often . . .